Ixazomib, lenalidomide, and dexamethasone for patients with POEMS syndrome.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Angela Dispenzieri, Martha Lacy, Michelle Mauermann, Betsy LaPlant, Ronald S. Go, Prashant Kapoor, Nelson Leung, Yi Lisa Hwa, Amy Fonder, Francis Buadi, Suzanne R. Hayman, John Anthony Lust, David Dingli, Wilson I. Gonsalves, Taxiarchis Kourelis, Rahma M. Warsame, S. Vincent Rajkumar, Shaji Kumar, Morie A. Gertz
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2955545015
